| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |